Cite
HARVARD Citation
Yamazoe, M. et al. (2023). Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer. Cancer science. 114 (2), pp. 546-560. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamazoe, M. et al. (2023). Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer. Cancer science. 114 (2), pp. 546-560. [Online].